Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants
Authors
Keywords
-
Journal
NEW ENGLAND JOURNAL OF MEDICINE
Volume 388, Issue 16, Pages 1451-1464
Publisher
Massachusetts Medical Society
Online
2023-04-06
DOI
10.1056/nejmoa2216480
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults
- (2023) Edward E. Walsh et al. NEW ENGLAND JOURNAL OF MEDICINE
- WHO preferred product characteristics for monoclonal antibodies for passive immunization against respiratory syncytial virus (RSV) disease in infants – Key considerations for global use
- (2022) Erin Sparrow et al. VACCINE
- Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis
- (2022) You Li et al. LANCET
- Prefusion F Protein–Based Respiratory Syncytial Virus Immunization in Pregnancy
- (2022) Eric A.F. Simões et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term Infants
- (2022) Laura L. Hammitt et al. NEW ENGLAND JOURNAL OF MEDICINE
- RSV Prevention in All Infants: Which Is the Most Preferable Strategy?
- (2022) Susanna Esposito et al. Frontiers in Immunology
- Vaccine Efficacy in Adults in a Respiratory Syncytial Virus Challenge Study
- (2022) Beate Schmoele-Thoma et al. NEW ENGLAND JOURNAL OF MEDICINE
- Maternal Vaccination and Risk of Hospitalization for Covid-19 among Infants
- (2022) Natasha B. Halasa et al. NEW ENGLAND JOURNAL OF MEDICINE
- Epidemiology of respiratory syncytial virus in children younger than 5 years in England during the COVID-19 pandemic, measured by laboratory, clinical, and syndromic surveillance: a retrospective observational study
- (2022) Megan Bardsley et al. LANCET INFECTIOUS DISEASES
- The burden of respiratory syncytial virus in healthy term-born infants in Europe: a prospective birth cohort study
- (2022) Joanne G Wildenbeest et al. Lancet Respiratory Medicine
- Examining the interseasonal resurgence of respiratory syncytial virus in Western Australia
- (2021) David Anthony Foley et al. ARCHIVES OF DISEASE IN CHILDHOOD
- Challenges of Assessing Community Mortality Due to Respiratory Viruses in Children Aged Less Than 5 Years
- (2021) Mauricio T Caballero et al. CLINICAL INFECTIOUS DISEASES
- Maternal RSV vaccine development. Where to from here?
- (2021) Ahinsa Gunatilaka et al. Human Vaccines & Immunotherapeutics
- Phase 1/2 Randomized Study of the Immunogenicity, Safety, and Tolerability of a Respiratory Syncytial Virus Prefusion F Vaccine in Adults With Concomitant Inactivated Influenza Vaccine
- (2021) Ann R Falsey et al. JOURNAL OF INFECTIOUS DISEASES
- A Randomized Phase 1/2 Study of a Respiratory Syncytial Virus Prefusion F Vaccine
- (2021) Edward E Walsh et al. JOURNAL OF INFECTIOUS DISEASES
- Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants
- (2020) Shabir A. Madhi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Global Perspectives on Immunization During Pregnancy and Priorities for Future Research and Development: An International Consensus Statement
- (2020) Bahaa Abu-Raya et al. Frontiers in Immunology
- The historical aspects of vaccination in pregnancy
- (2020) David William Mackin et al. BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY
- Suptavumab for the Prevention of Medically Attended Respiratory Syncytial Virus Infection in Preterm Infants
- (2020) Eric A F Simões et al. CLINICAL INFECTIOUS DISEASES
- Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case-control study
- (2019) Katherine L. O'Brien et al. LANCET
- Biology of Infection and Disease Pathogenesis to Guide RSV Vaccine Development
- (2019) Seyhan Boyoglu-Barnum et al. Frontiers in Immunology
- Prevention of Pediatric Respiratory Syncytial Virus Lower Respiratory Tract Illness: Perspectives for the Next Decade
- (2019) Sofia S. Aranda et al. Frontiers in Immunology
- Safety and Immunogenicity of a Respiratory Syncytial Virus Fusion (F) Protein Nanoparticle Vaccine in Healthy Third-Trimester Pregnant Women and Their Infants
- (2019) Flor M Muňoz et al. JOURNAL OF INFECTIOUS DISEASES
- Viral Bronchiolitis in Children
- (2016) H. Cody Meissner NEW ENGLAND JOURNAL OF MEDICINE
- Respiratory syncytial virus hospitalization and mortality: Systematic review and meta-analysis
- (2016) Renato T. Stein et al. PEDIATRIC PULMONOLOGY
- Prefusion F–specific antibodies determine the magnitude of RSV neutralizing activity in human sera
- (2015) Joan O. Ngwuta et al. Science Translational Medicine
- Neutralizing epitopes on the respiratory syncytial virus fusion glycoprotein
- (2015) Jason S McLellan Current Opinion in Virology
- Respiratory Syncytial Virus Transplacental Antibody Transfer and Kinetics in Mother-Infant Pairs in Bangladesh
- (2014) Helen Y. Chu et al. JOURNAL OF INFECTIOUS DISEASES
- The Level and Duration of RSV-Specific Maternal IgG in Infants in Kilifi Kenya
- (2009) Rachel Ochola et al. PLoS One
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started